Limited Competition: Lasker Clinical Research Scholars Transition Award (R00) | PAR 17 450

Opportunity Information: Apply for PAR 17 450

The Limited Competition: Lasker Clinical Research Scholars Transition Award (R00) (Funding Opportunity Number PAR-17-450) is a National Institutes of Health (NIH) grant opportunity designed specifically for participants already in the Lasker Clinical Research Scholars Program who are in the intramural phase (often referred to as Si2). Its main purpose is to help early-career, independent clinical researchers move from the NIH intramural environment into an extramural setting while keeping strong, stable research support in place during that transition. In practice, it functions as a bridge that allows a current Lasker Scholar to establish or continue an independent research program at an outside institution with NIH backing.

This announcement is limited in competition, meaning it is not open to the general research community in the way many NIH opportunities are. Eligibility is aimed at current Lasker awardees (Si2) who are ready to apply for the R00 transition phase. The R00 phase can provide up to five years of NIH support for research conducted at an extramural research facility, which generally means a university, medical center, research institute, or other qualifying organization outside NIH. The intent is to give investigators enough runway to build momentum in a new institutional home, strengthen their clinical research program, and compete successfully for longer-term independent funding.

The award is a grant mechanism and falls under the broad federal activity categories of Health (and related areas such as Environment, Food and Nutrition), with CFDA numbers listed as 93.113 and 93.847. The listed award ceiling is $499,000, which indicates the maximum amount that may be provided under the terms described in the opportunity. The opportunity was created on August 8, 2017, and the original closing date shown in the source information is May 7, 2020, which is important for anyone checking historical records or trying to confirm whether the announcement is still active or has been superseded by a newer version.

A wide range of organization types are identified as eligible applicants in the source data, reflecting the fact that NIH grants can be administered through many kinds of U.S.-based entities. These include state, county, and city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments and certain tribal organizations; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status; for-profit organizations (other than small businesses); and small businesses. The announcement also explicitly calls out additional eligible applicant categories that NIH often highlights to encourage broad institutional participation, including Alaska Native and Native Hawaiian Serving Institutions, AANAPISIS institutions, Hispanic-serving institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, regional organizations, eligible federal agencies, and U.S. territories or possessions.

At the same time, the opportunity is clear about restrictions involving foreign involvement. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply. Non-domestic components of U.S. organizations are also not eligible, and foreign components (as NIH defines them in the NIH Grants Policy Statement) are not allowed. These restrictions mean the R00-supported work must be positioned within eligible U.S.-based applicant organizations and cannot be structured around foreign components as part of the funded project.

Overall, this funding opportunity is best understood as a targeted NIH transition award for a very specific group: current Lasker Clinical Research Scholars who have reached the point where they are moving their independent clinical research program into an extramural institution. The R00 phase is meant to preserve continuity of funding and help the investigator establish a durable, externally based research program during a critical early-career period.

• The National Institutes of Health in the environment, food and nutrition, health sector is offering a public funding opportunity titled "Limited Competition: Lasker Clinical Research Scholars Transition Award (R00)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.113, 93.847.
• This funding opportunity was created on 2017-08-08.
• Applicants must submit their applications by 2020-05-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Each selected applicant is eligible to receive up to $499,000.00 in funding.
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.

Apply for PAR 17 450

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: